| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |